Product Categories
| Country: | China |
|---|---|
| Tel: | 021-021-54306202 |
| Mobile: | +8618917919676 |
| E-mail: | info@hanhongsci.com |
| QQ: | 2355241802 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| KB3022 | C25H24N2O4S | 101001-34-7 | Details |
| KX2-391 | C26H29N3O3 | 897016-82-9 | Details |
| Verubulin | C17H17N3O | 827031-83-4 | Details |
| (1R,2R)-2-fluorocyclopropanecarboxylic acid | C4H5FO2 | 127199-13-7 | Details |
| Apcin | C13H14Cl3N7O4 | 300815-04-7 | Details |
| PQR-530 | C18H23F2N7O2 | 1927857-61-1 | Details |
| Parimifasor | C18H11Cl2F4N5O | 1796641-10-5 | Details |
| RS 25344 hydrochloride | C19H14ClN5O4 | 152815-28-6 | Details |
| EG1 (Pax2 inhibitor EG1) | C22H18N2O5 | 693241-54-2 | Details |
| MBX2329 | C16H26ClNO | 1438272-42-4 | Details |
| RBPJ Inhibitor-1(RIN1) | Details |
| N-0437 | C19H25NOS | 92206-54-7 | Details |
| CC-885 | C22H21ClN4O4 | 1010100-07-8 | Details |
| (E)-(5-nitrofuran-2-yl)methylideneamino]urea | C6H6N4O4 | 112574-44-4 | Details |
| Cadralazine | C12H21N5O3 | 64241-34-5 | Details |
| STAT3-IN-1 | C28H29NO6 | 2059952-75-7 | Details |
| CC-90009 | C22H18ClF2N3O4 | 1860875-51-9 | Details |
| GSK778 | C30H33N5O3 | 2451862-42-1 | Details |
| ARP 100 | C17H20N2O5S | 704888-90-4 | Details |
| 2-(3,4-Dihydroxy-benzylidene)-benzofuran-3-one, Sphingosine Kinase Inhibitor V | C15H10O4 | 24418-86-8 | Details |
| LMK-235 | C15H22N2O4 | 1418033-25-6 | Details |
| (R)-N- (4-(chlorodifluoromethoxy)phenyl)- 6-(3- hydroxypyrrolidin-1- yl)-5- (1H-pyrazol- 5-yl)nicotinamide | C20H18ClF2N5O3 | 1492952-76-7 | Details |
| 1-Pentanone, 1-(1,3,4,9-tetrahydro-1-phenyl-2H-pyrido[3,4-b]indol-2-yl)- | C22H24N2O | 334939-35-4 | Details |
| N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea | C13H12ClN3O | 97627-24-2 | Details |
| N-(2-CHLOROETHYL)-N-ETHYL-2-BROMOBENZYLAMINE HYDROCHLORIDE | C11H16BrCl2N | 40616-75-9 | Details |
| MP07-66 | C19H33NO3 | 1938056-90-6 | Details |
| 4-KETO ALL-TRANS-RETINOIC ACID METHYL ESTER | C21H28O3 | 38030-58-9 | Details |
| 4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- | C25H22F2N4O2 | 2314467-59-7 | Details |
| STM2457 | C25H28N6O2 | 2499663-01-1 | Details |
| 2-Pyridinamine, 5,6-bis(4-methoxy-3-methylphenyl)- | C21H22N2O2 | 2306039-66-5 | Details |
| 4-Pyrimidinamine, N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-(4-morpholinyl)- | C18H24F2N6O | 2167246-24-2 | Details |
| Benzamide, N-hydroxy-4-[[[[(2-methoxyphenyl)amino]carbonyl]amino]methyl]- | C16H17N3O4 | 1454902-97-6 | Details |
| (S)-(+)-2-METHYLBUTYL P-[(P-METHOXYBENZYLIDENE)AMINO]CINNAMATE | C22H25NO3 | 24140-30-5 | Details |
| BI 2536 | C28H39N7O3 | 755038-02-9 | Details |
| N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide) | C16H14Cl2N2O4S | 17328-16-4 | Details |
| N-[4-(2-BROMO-4,5-DIFLUOROPHENOXY)PHENYL]-L-ASPARAGINE | C16H13BrF2N2O4 | 868359-05-1 | Details |
| TMEM16AInhibitorsRevealTMEM16A(T16Ainh-A01) | C19H20N4O3S2 | 552309-42-9 | Details |
| N'-((6-Methylpyridin-2-yl)methylene)pyrrolidine-1-carbothiohydrazide | C12H16N4S | 907549-72-8 | Details |
| (4-(4-methoxyphenyl)piperazin-1-yl)(2-(4-methylpiperidin-1-yl)benzo[d]thiazol-6-yl)methanone | C25H30N4O2S | 906258-69-3 | Details |
| Benzeneacetamide, N-[3-[(3,4-dihydro-2,4-dioxo-3-propylthieno[3,2-d]pyrimidin-1(2H)-yl)methyl]phenyl]- | C24H23N3O3S | 2098776-03-3 | Details |
| Ethanone, 2-chloro-1-(3-indolyl)- | C10H8ClNO | 28755-03-5 | Details |
| AC710 | C31H42N6O4 | 1351522-04-7 | Details |
| ZL006 | C14H11Cl2NO4 | 1181226-02-7 | Details |
| 1-(5-Chloro-2-hydroxyphenyl)-ethanone 2-(2,4,6-trichlorophenyl)hydrazone | C14H10Cl4N2O | 219315-22-7 | Details |
| Metronidazole-Impurity-11 | C11H10O2 | 1410831-12-7 | Details |
| CLONIDINE RELATED COMPOUND A (25 MG) (ACET-YLCLONIDINE) | C11H11Cl2N3O | 54707-71-0 | Details |
| N2,N4-bis(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine | C22H20N6 | 1071098-42-4 | Details |
| (S)-2-Amino-N1-benzhydrylpentanediamide | C18H21N3O2 | 2429878-52-2 | Details |
| 2-methyl-5-nitroimidazol-1-ylacetic acid | C6H7N3O4 | 1010-93-1 | Details |
| 3-N-BUTYLPHTHALIDE | C12H14O2 | 6066-49-5 | Details |
| Oxiconazole nitrate | C18H13Cl4N3O | 64211-46-7 | Details |
| MF-438 | C19H18F3N5OS | 921605-87-0 | Details |
| CDKI-73 | C15H15FN6O2S2 | 1421693-22-2 | Details |
| CHR 6494 trifluoroacetate | C18H17F3N6O2 | 1458630-17-5 | Details |
| ML-180 | C20H25ClN4O2 | 863588-32-3 | Details |
| 2-(4-fluorophenyl)-3-(isopropyl(methyl)amino)quinoxaline-6-carboxylic acid | C19H18FN3O2 | 1268863-35-9 | Details |
| CYCLIZINE HCL | C18H22N2 | 82-92-8 | Details |
| Parsaclisib | C20H22ClFN6O2 | 1426698-88-5 | Details |
| 1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C16H15N5 | 1357349-91-7 | Details |
| 3-(3-Bromo-2-thienyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene fumarate | C16H18BrNO4S | 216853-60-0 | Details |
| KI-7 | C23H18N2O2 | 1489263-00-4 | Details |
| GOT1 inhibitor 2c | C19H19ClN4O | 732973-87-4 | Details |
| 1H-Benzotriazole-7-carboxylic acid, 1-methyl-5-(2'-methyl[1,1'-biphenyl]-4-yl)- | C21H17N3O2 | 1623416-31-8 | Details |
| Benzeneacetonitrile, 4-cyano-α-[[4-[[2-(dimethylamino)ethyl]methylamino]phenyl]methylene]- | C21H22N4 | 2530161-67-0 | Details |
| 5-(3-(1-naphthoyl)-1H-indol-1-yl)pentanenitrile | C24H20N2O | 335161-19-8 | Details |
| N,N-diethyl-2-((6-methylpyridin-2-yl)methylene)hydrazinecarbothioamide | C12H18N4S | 210700-64-4 | Details |
| 1-METHYL-4-[THIOXANTHEN-9-YLIDENE]PIPERIDINE MALEATE SALT | C23H23NO4S | 13187-06-9 | Details |
| GS143 | C28H19FN2O4 | 916232-21-8 | Details |
| 2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]- | C21H18FN5O5S | 853953-65-8 | Details |
| BDTX-189 | C29H29ClN6O4 | 2414572-47-5 | Details |
| Bis(trans-cinnamic acid)anhydride | C18H14O3 | 21947-71-7 | Details |
| 1-(3-Nitrophenyl)-3-(4-pyridinylmethyl)-pyrido[2,3-d]pyrimidine-2,3-(1H,3H)-dionehydrochloride | C19H13N5O4 | 152814-89-6 | Details |
| 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine | C25H27N5 | 162640-98-4 | Details |
| MIT 9952-53 | C12H23N3S | 321673-30-7 | Details |
| N-(1,2-Dimethyl-1H-benzo[d]imidazol-5-yl)-1-(3-fluorobenzyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxamide | C24H20FN5O | 920978-76-3 | Details |
| 2-(N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)AMINO)-2-DEOXYGLUCOSE | C12H14N4O8 | 186689-07-6 | Details |
| 1,6-dimethyl-3-phenylpyrimido[5,4-e][1,2,4]triazine-5,7-dione | C13H11N5O2 | 32502-63-9 | Details |
| TH1020 | C23H15N7S2 | 1841460-82-9 | Details |
| Benzonitrile, 3-[[(1S,2S,3R)-2,3-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5-fluoro- | C17H12F3NO4S | 1672668-24-4 | Details |
| (4-benzylpiperazin-1-yl)(2-(4-methylpiperidin-1-yl)benzo[d]thiazol-6-yl)methanone | C25H30N4OS | 906258-48-8 | Details |
| MYF-01-37 | C15H17F3N2O | 2416417-65-5 | Details |
| TOCAINIDE | C11H16N2O | 41708-72-9 | Details |
| A 1120 | C20H19F3N2O3 | 1152782-19-8 | Details |
| Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) | C8H11N3O6 | 39925-19-4 | Details |
| ALW-II-41-27 | C32H32F3N5O2S | 1186206-79-0 | Details |
| MLI-2 | C21H25N5O2 | 1627091-47-7 | Details |
| BETd-260 | C43H46N10O6 | 2093388-62-4 | Details |
| MYCMI-6 | C20H19N7O | 681282-09-7 | Details |
| EGFR-IN-5 | C31H38FN9O | 2225887-26-1 | Details |
| Tryptophan, N-indol-3-ylacetyl- (6CI) | C21H19N3O3 | 57105-53-0 | Details |
| Paquinimod | C21H22N2O3 | 248282-01-1 | Details |
| 2-Chloro-N-[(9H-fluoren-9-ylamino)carbonyl]-6-fluorobenzamide | C21H14ClFN2O2 | 1186372-20-2 | Details |
| 2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime | C18H19NO3 | 321688-88-4 | Details |
| CHR-6494 | C16H16N6 | 1333377-65-3 | Details |
| N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide | C28H32Cl2N4O6S2 | 942206-85-1 | Details |
| KM91104 | C14H12N2O4 | 304481-60-5 | Details |
| Butamirate Impurity 1 | C14H21NO | 92321-53-4 | Details |
| 10-methyl-9-(phenoxycarbonyl) Acridinium (trifluoromethylsulfonate) | C22H16F3NO5S | 161006-14-0 | Details |
| N-OMEGA-HYDROXYL-NOR-L-ARGININE, DIHYDROCHLORIDE | C5H12N4O3 | 291758-32-2 | Details |
| NS3861 >=98% (HPLC) | C12H14BrNS | 216853-59-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 | ||||